32 related articles for article (PubMed ID: 27173725)
1. TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets.
Yamada N; Miyamoto M; Isogaya M; Suzuki M; Ikezawa S; Ohno M; Otake A; Umemura K
J Thromb Haemost; 2003 Aug; 1(8):1813-9. PubMed ID: 12911598
[TBL] [Abstract][Full Text] [Related]
2. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase.
Zhang SH; Zhang Y; Shen J; Zhang S; Chen L; Gu J; Mruk JS; Cheng G; Zhu L; Kunapuli SP; Ding Z
J Thromb Haemost; 2013 Oct; 11(10):1855-66. PubMed ID: 23902231
[TBL] [Abstract][Full Text] [Related]
3. In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation.
Armstrong PC; Leadbeater PD; Chan MV; Kirkby NS; Jakubowski JA; Mitchell JA; Warner TD
J Thromb Haemost; 2011 Mar; 9(3):552-61. PubMed ID: 21143373
[TBL] [Abstract][Full Text] [Related]
4. Platelet dysfunction associated with the novel Trp29Cys thromboxane A₂ receptor variant.
Mumford AD; Nisar S; Darnige L; Jones ML; Bachelot-Loza C; Gandrille S; Zinzindohoue F; Fischer AM; Mundell SJ; Gaussem P;
J Thromb Haemost; 2013 Mar; 11(3):547-54. PubMed ID: 23279270
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2.
Armstrong PC; Truss NJ; Ali FY; Dhanji AA; Vojnovic I; Zain ZN; Bishop-Bailey D; Paul-Clark MJ; Tucker AT; Mitchell JA; Warner TD
J Thromb Haemost; 2008 Nov; 6(11):1933-43. PubMed ID: 18752570
[TBL] [Abstract][Full Text] [Related]
6. A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression.
Rossiello MR; Momi S; Caracchini R; Giannini S; Guglielmini G; Monopoli A; Ongini E; Semeraro N; Colucci M; Gresele P
J Thromb Haemost; 2005 Nov; 3(11):2554-62. PubMed ID: 16241953
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength.
Jones WL; Ramos CR; Banerjee A; Moore EE; Hansen KC; Coleman JR; Kelher M; Neeves KB; Silliman CC; Di Paola J; Branchford B
Platelets; 2022 Nov; 33(8):1119-1131. PubMed ID: 35659185
[TBL] [Abstract][Full Text] [Related]
8. TxA
Ahmad F
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936415
[No Abstract] [Full Text] [Related]
9. Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension.
Karpov AA; Vaulina DD; Smirnov SS; Moiseeva OM; Galagudza MM
Heliyon; 2022 Mar; 8(3):e09014. PubMed ID: 35295664
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis.
Queck A; Thomas D; Jansen C; Schreiber Y; Rüschenbaum S; Praktiknjo M; Schwarzkopf KM; Mücke MM; Schierwagen R; Uschner FE; Meyer C; Clària J; Zeuzem S; Geisslinger G; Trebicka J; Lange CM
PLoS One; 2019; 14(10):e0222840. PubMed ID: 31644538
[TBL] [Abstract][Full Text] [Related]
11. YiqiHuoxue Decoction and Its Ethanol Precipitation Show Anti-Platelet and Antithrombotic Effects by Suppressing Thromboxane B2 Formation.
Wu H; Lei Z; Gao S; Dai L; Han Y; Gao H; Wang X; Wang Z; Han L
Acta Cardiol Sin; 2019 Sep; 35(5):524-533. PubMed ID: 31571802
[TBL] [Abstract][Full Text] [Related]
12. Investigation of a Thromboxane A
Alshbool FZ; Karim ZA; Espinosa EVP; Lin OA; Khasawneh FT
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936414
[TBL] [Abstract][Full Text] [Related]
13. Refinement of Mouse Protocols for the Study of Platelet Thromboembolic Responses In Vivo.
Rauzi F; Smyth E; Emerson M
Thromb Haemost; 2017 Dec; 117(12):2283-2290. PubMed ID: 29212116
[TBL] [Abstract][Full Text] [Related]
14. Toxin Fused with SUMO Tag: A New Expression Vector Strategy to Obtain Recombinant Venom Toxins with Easy Tag Removal inside the Bacteria.
Shimokawa-Falcão LH; Caporrino MC; Barbaro KC; Della-Casa MS; Magalhães GS
Toxins (Basel); 2017 Feb; 9(3):. PubMed ID: 28264436
[TBL] [Abstract][Full Text] [Related]
15. Effects of Aspirin on Endothelial Function and Hypertension.
Dzeshka MS; Shantsila A; Lip GY
Curr Hypertens Rep; 2016 Nov; 18(11):83. PubMed ID: 27787837
[TBL] [Abstract][Full Text] [Related]
16. A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models.
Huang SW; Kuo HL; Hsu MT; Tseng YJ; Lin SW; Kuo SC; Peng HC; Lien JC; Huang TF
Thromb Haemost; 2016 Aug; 116(2):285-99. PubMed ID: 27173725
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Effects of an Orally Active Thromboxane A2 Receptor Antagonist, nstpbp5185, on Atherosclerosis in ApoE-Deficient Mice.
Huang SW; Lien JC; Kuo SC; Huang TF
Thromb Haemost; 2018 Feb; 118(2):401-414. PubMed ID: 29378362
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
